|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.530 CNY | +1.35% |
|
+2.87% | +12.22% |
| Capitalization | 7.69B 1.07B 917M 854M 795M 1.47B 92.03B 1.63B 10.24B 3.91B 43.09B 4.02B 3.94B 158B | P/E ratio 2025 * |
30.1x | P/E ratio 2026 * | 25.1x |
|---|---|---|---|---|---|
| Enterprise value | 7.69B 1.07B 917M 854M 795M 1.47B 92.03B 1.63B 10.24B 3.91B 43.09B 4.02B 3.94B 158B | EV / Sales 2025 * |
1.15x | EV / Sales 2026 * | 1.06x |
| Free-Float |
47.56% | Yield 2025 * |
1.46% | Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
| 1 day | +1.35% | ||
| 1 week | +2.87% | ||
| Current month | +2.73% | ||
| 1 month | +6.81% | ||
| 3 months | +8.19% | ||
| 6 months | +22.64% | ||
| Current year | +12.22% |
| 1 week | 7.31 |  | 7.68 |
| 1 month | 6.9 | | 7.68 |
| Current year | 5.94 | | 7.68 |
| 1 year | 5.47 | | 7.95 |
| 3 years | 5.47 | | 16.23 |
| 5 years | 5.47 | | 20.77 |
| 10 years | 5.47 | | 20.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dong Xun Wu
CEO | Chief Executive Officer | 60 | 2017-07-20 |
Jin Jian Huang
DFI | Director of Finance/CFO | 62 | 2018-08-30 |
Yan Shang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jian Cheng Wang
CHM | Chairman | 62 | 2016-12-08 |
Xue Lin Li
BRD | Director/Board Member | 60 | 2017-09-10 |
Shi Zhong Hou
CHM | Chairman | 60 | 2014-01-16 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.35% | +2.87% | +8.66% | -39.71% | 1.07B | ||
| -2.42% | -2.65% | -12.82% | -12.47% | 68.99B | ||
| -0.93% | +1.78% | +9.00% | -26.31% | 7.4B | ||
| +0.62% | +1.34% | -3.45% | +3.70% | 3.67B | ||
| -1.16% | +1.04% | -0.87% | -7.96% | 3.34B | ||
| -2.38% | -0.10% | +15.04% | -8.78% | 2.3B | ||
| -1.09% | +10.00% | +76.00% | +56.90% | 1.25B | ||
| +1.34% | -0.30% | +46.06% | +9.34% | 1.25B | ||
| +0.52% | +2.09% | -19.09% | -37.00% | 1.08B | ||
| -0.06% | -0.81% | +20.02% | -38.13% | 1.03B | ||
| Average | -0.42% | +1.32% | +13.86% | -10.04% | 9.14B | |
| Weighted average by Cap. | -1.96% | -1.64% | -6.97% | -12.34% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.71B 935M 800M 745M 693M 1.28B 80.26B 1.42B 8.93B 3.41B 37.58B 3.51B 3.44B 138B | 7.28B 1.02B 869M 809M 753M 1.39B 87.18B 1.55B 9.7B 3.71B 40.82B 3.81B 3.73B 150B |
| Net income | 260M 36.3M 31.04M 28.91M 26.89M 49.69M 3.11B 55.22M 346M 132M 1.46B 136M 133M 5.35B | 304M 42.38M 36.24M 33.75M 31.39M 58.01M 3.64B 64.46M 404M 155M 1.7B 159M 156M 6.24B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
4,299
Sector
Pharmaceuticals
Calendar
Aug. 27
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 7.530 ¥ | +1.35% | 20,668,030 |
| 25-07-10 | 7.430 ¥ | +1.36% | 11,242,120 |
| 25-07-09 | 7.330 ¥ | -0.95% | 10,189,890 |
| 25-07-08 | 7.400 ¥ | -0.13% | 8,449,607 |
| 25-07-07 | 7.410 ¥ | +1.23% | 13,961,040 |
End-of-day quote Shanghai S.E., July 10, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.530CNY
Average target price
7.873CNY
Spread / Average Target
+4.56%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600195 Stock
Select your edition
All financial news and data tailored to specific country editions
